Exploring Novel Variants of the Cytochrome P450 Reductase Gene (<i>POR</i>) from the Genome Aggregation Database by Integrating Bioinformatic Tools and Functional Assays

Cytochrome P450 oxidoreductase (POR) is an essential redox partner for steroid and drug-metabolizing cytochromes P450 located in the endoplasmic reticulum. Mutations in <i>POR</i> lead to metabolic disorders, including congenital adrenal hyperplasia, and affect the metabolism of steroids...

Full description

Bibliographic Details
Main Authors: Maria Natalia Rojas Velazquez, Søren Therkelsen, Amit V. Pandey
Format: Article
Language:English
Published: MDPI AG 2023-11-01
Series:Biomolecules
Subjects:
Online Access:https://www.mdpi.com/2218-273X/13/12/1728
_version_ 1797381898907942912
author Maria Natalia Rojas Velazquez
Søren Therkelsen
Amit V. Pandey
author_facet Maria Natalia Rojas Velazquez
Søren Therkelsen
Amit V. Pandey
author_sort Maria Natalia Rojas Velazquez
collection DOAJ
description Cytochrome P450 oxidoreductase (POR) is an essential redox partner for steroid and drug-metabolizing cytochromes P450 located in the endoplasmic reticulum. Mutations in <i>POR</i> lead to metabolic disorders, including congenital adrenal hyperplasia, and affect the metabolism of steroids, drugs, and xenobiotics. In this study, we examined approximately 450 missense variants of the <i>POR</i> gene listed in the Genome Aggregation Database (gnomAD) using eleven different in silico prediction tools. We found that 64 novel variants were consistently predicted to be disease-causing by most tools. To validate our findings, we conducted a population analysis and selected two variations in <i>POR</i> for further investigation. The human POR wild type and the R268W and L577P variants were expressed in bacteria and subjected to enzyme kinetic assays using a model substrate. We also examined the activities of several cytochrome P450 proteins in the presence of POR (WT or variants) by combining P450 and reductase proteins in liposomes. We observed a decrease in enzymatic activities (ranging from 35% to 85%) of key drug-metabolizing enzymes, supported by POR variants R288W and L577P compared to WT-POR. These results validate our approach of curating a vast amount of data from genome projects and provide an updated and reliable reference for diagnosing POR deficiency.
first_indexed 2024-03-08T20:58:09Z
format Article
id doaj.art-d858fead6721452aacf50dd7e6ad4754
institution Directory Open Access Journal
issn 2218-273X
language English
last_indexed 2024-03-08T20:58:09Z
publishDate 2023-11-01
publisher MDPI AG
record_format Article
series Biomolecules
spelling doaj.art-d858fead6721452aacf50dd7e6ad47542023-12-22T13:55:55ZengMDPI AGBiomolecules2218-273X2023-11-011312172810.3390/biom13121728Exploring Novel Variants of the Cytochrome P450 Reductase Gene (<i>POR</i>) from the Genome Aggregation Database by Integrating Bioinformatic Tools and Functional AssaysMaria Natalia Rojas Velazquez0Søren Therkelsen1Amit V. Pandey2Division of Pediatric Endocrinology, Department of Pediatrics, University Children’s Hospital Bern, 3010 Bern, SwitzerlandDivision of Pediatric Endocrinology, Department of Pediatrics, University Children’s Hospital Bern, 3010 Bern, SwitzerlandDivision of Pediatric Endocrinology, Department of Pediatrics, University Children’s Hospital Bern, 3010 Bern, SwitzerlandCytochrome P450 oxidoreductase (POR) is an essential redox partner for steroid and drug-metabolizing cytochromes P450 located in the endoplasmic reticulum. Mutations in <i>POR</i> lead to metabolic disorders, including congenital adrenal hyperplasia, and affect the metabolism of steroids, drugs, and xenobiotics. In this study, we examined approximately 450 missense variants of the <i>POR</i> gene listed in the Genome Aggregation Database (gnomAD) using eleven different in silico prediction tools. We found that 64 novel variants were consistently predicted to be disease-causing by most tools. To validate our findings, we conducted a population analysis and selected two variations in <i>POR</i> for further investigation. The human POR wild type and the R268W and L577P variants were expressed in bacteria and subjected to enzyme kinetic assays using a model substrate. We also examined the activities of several cytochrome P450 proteins in the presence of POR (WT or variants) by combining P450 and reductase proteins in liposomes. We observed a decrease in enzymatic activities (ranging from 35% to 85%) of key drug-metabolizing enzymes, supported by POR variants R288W and L577P compared to WT-POR. These results validate our approach of curating a vast amount of data from genome projects and provide an updated and reliable reference for diagnosing POR deficiency.https://www.mdpi.com/2218-273X/13/12/1728cytochrome P450 oxidoreductasePORgnomADCAHdrug metabolismsteroid hormones
spellingShingle Maria Natalia Rojas Velazquez
Søren Therkelsen
Amit V. Pandey
Exploring Novel Variants of the Cytochrome P450 Reductase Gene (<i>POR</i>) from the Genome Aggregation Database by Integrating Bioinformatic Tools and Functional Assays
Biomolecules
cytochrome P450 oxidoreductase
POR
gnomAD
CAH
drug metabolism
steroid hormones
title Exploring Novel Variants of the Cytochrome P450 Reductase Gene (<i>POR</i>) from the Genome Aggregation Database by Integrating Bioinformatic Tools and Functional Assays
title_full Exploring Novel Variants of the Cytochrome P450 Reductase Gene (<i>POR</i>) from the Genome Aggregation Database by Integrating Bioinformatic Tools and Functional Assays
title_fullStr Exploring Novel Variants of the Cytochrome P450 Reductase Gene (<i>POR</i>) from the Genome Aggregation Database by Integrating Bioinformatic Tools and Functional Assays
title_full_unstemmed Exploring Novel Variants of the Cytochrome P450 Reductase Gene (<i>POR</i>) from the Genome Aggregation Database by Integrating Bioinformatic Tools and Functional Assays
title_short Exploring Novel Variants of the Cytochrome P450 Reductase Gene (<i>POR</i>) from the Genome Aggregation Database by Integrating Bioinformatic Tools and Functional Assays
title_sort exploring novel variants of the cytochrome p450 reductase gene i por i from the genome aggregation database by integrating bioinformatic tools and functional assays
topic cytochrome P450 oxidoreductase
POR
gnomAD
CAH
drug metabolism
steroid hormones
url https://www.mdpi.com/2218-273X/13/12/1728
work_keys_str_mv AT marianataliarojasvelazquez exploringnovelvariantsofthecytochromep450reductasegeneiporifromthegenomeaggregationdatabasebyintegratingbioinformatictoolsandfunctionalassays
AT sørentherkelsen exploringnovelvariantsofthecytochromep450reductasegeneiporifromthegenomeaggregationdatabasebyintegratingbioinformatictoolsandfunctionalassays
AT amitvpandey exploringnovelvariantsofthecytochromep450reductasegeneiporifromthegenomeaggregationdatabasebyintegratingbioinformatictoolsandfunctionalassays